Fatih KARA, Emine ALP MEŞE, Ersin NAZLICAN, Tufan NAYİR, Musa ŞAHİN

Effects of immunization program on morbidity and mortality rates of vaccine-preventable diseases in Turkey

Background/aim: This study aims to serve as a unique consolidated source in Turkey’s vaccination history and as an example for other countries by objectively revealing the change in mortality and morbidity rates in Turkey following the beginning of vaccination without asserting any claim on the benefits or risks of vaccines. This unbiased research will also help health professionals identify the challenges more easily when they face with the people who hesitate to vaccinate their children. Materials and methods: Descriptive research design is adopted in this study. The coverages of vaccinations, mortality, and morbidity rates were identified through a retrospective analysis of the data provided from the Ministry of Health of Turkey. The data provided by the Turkish Statistical Institute were used for the identification of the population by the year. Mortality and morbidity rates were calculated based on these data Results: Morbidity rates, mortality rates, and vaccine coverages are all presented in years. Successful interventions have been observed in the eradication of polio, the elimination of maternal neonatal tetanus, and also in combating with other diseases. A decline in pertussis mortality from 0.59 to 0.06 along with a decline in diphtheria morbidity under to 0.0001 were recognized; additionally the last death due to poliomyelitis was observed in 1998. Only 4 deaths occurred in the measles epidemic in 2013. With the initiation of vaccination, both the morbidity of the rubella with the ratio of 3.12/100,000 and the mortality of pumps with the ratio of 25/100,000 fell to zero. Also, no death due to neonatal tetanus has been recorded since 2014. Conclusion: The present study demonstrates that many possible diseases and deaths have been prevented through vaccination studies. In this regard, this study demonstrating the importance of vaccination presents that all individuals in the society have a responsibility in this scope when the communicable diseases and wars are taken into consideration. The main responsibility is to ensure that they and their children are vaccinated against communicable diseases that are risky for society’s health.

PDF

___

1. Yurdakul E. Significant infectious disease outbreaks in history. Turkiye Klinikleri Public Health-Special Topics 2015;1(3):1-6.
2. Gülcü S, Aslan S. Vaccine application on children: a current review. Journal of Düzce University Health Sciences Institute 2018; 8(1): 34-43. https://doi.org/10.33631/duzcesbed.589195
3. Şimşek OF. An overview of the extended immunization program. Osmangazi Tıp Dergisi 2020; 3: 6-14. https://doi. org/10.20515/otd.681563
4. Saraç A, Tumay Ş, Noyan N. Türkiye Cumhuriyeti Sağlık Bakanlığı Polio eradikasyon rehberi.5. baskı. Ankara, Türkiye: Sağlık Bakanlığı; 2001.
5. Bulaşıcı Hastalıklar Dairesi Başkanlığı. Türkiye Cumhuriyeti Sağlık Bakanlığı bulaşıcı hastalıklar rehberi. Ankara, Türkiye: Sağlık Bakanlığı; 2018.
6. Kayiran S, Gürakan B. Neonatal Pertussis: A Case Report. Journal of Child 2010; 10 (4): 207-210. doi:10.5222/j.child.2010.207
7. Sezen I. Turan M. Kaya A. Syrian Refugees In Turkey and Associated with Infectious Diseases. GUJHS 2018; 7(4): 119- 127.
8. Wang H, Tafalla M, Hanssens L, Dolhain J. A review of Haemophilus influenzae disease in Europe from 2000–2014: challenges, successes and the contribution of hexavalent combination vaccines, Expert Review of Vaccines 2017; 16(11):1095-1105. https://doi.org/10.1080/14760584.2017.1383 157
9. Soeters H, Blain A, Pondo T, Doman B, Farley M et al. Current epidemiology and trends in invasive haemophilus influenzae disease—United States, 2009–2015. Clinical Infectious Diseases 2018; 67(6): 881–889. https://doi.org/10.1093/cid/ciy187
10. Ceyhan M, Gürler N, Ozsurekci Y, Keser M, Aycan E et al. Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae Type B and Streptococcus Pneumoniae during 2005– 2012 in Turkey, A multicenter prospective surveillance study. Human Vaccines & Immunotherapeutics 2014; 10(9): 2706 - 2712. https://doi.org/10.4161/hv.29678
11. Anderson RM, Crombie JA, Grenfell BT. The Epidemiology of Mumps in the UK: A Preliminary Study of Virus Transmission, Herd Immunity and the Potential Impact of Immunization. Epidemiol Infect 1987; 99(1): 65-84. https://doi.org/10.1017/ S0950268800066875
12. Beleni AI, Borgmann S. Mumps in the vaccination age: Global epidemiology and the situation in Germany. International Journal of Environmental Research and Public Health 2018; 15(8): 1618-1632. https://doi.org/10.3390/ijerph15081618
13. Damm O, Witte J, Wetzka S, Prosser C, Braun S et al. Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review. International Journal of Public Health 2016; 61(8): 847-860. https://doi.org/10.1007/s00038-016-0842-8
14. Muscat M, Shefer A, Ben Mamou M, Spataru R, Jankovic D et al. The state of measles and rubella in the WHO European Region, 2013. Clinical Microbiology and Infection 2014; 20: 12-18. https://doi.org/10.1111/1469-0691.12584
15. Ayvaz A, Nur N, Engin A, Çetinkaya S. Prevalence of hepatitis B and C in first grade primary school children living in Sivas, Turkey. Turkish Archives of Pediatrics 2010; 45: 132-136. doi:10.4274/tpa.45.132
16. Kılıçaslan B, Altınkaynak S, Selimoğlu MA. Atatürk Üniversitesi Tıp Fakültesi The serology of Hepatitis B virus in children living in Erzurum. Çocuk Dergisi 2004; 4: 37-41.
17. Arabacı F, Demirli H. The seroprevalence of hepatitis A and B in children 6-10 years of age. Enfeksiyon Dergisi 2005; 19: 457- 460.
18. Wolfson LJ, Daniels VJ, Pillsbury M, Kurugol Z, Yardimci C et al. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model. PloS ONE 2019; 14(8): e0220921. https://doi.org/10.1371/journal. pone.0220921